HUSHIVY
Live / Registered — Registered (as of 20 Feb 2024)
What this means for you
Registered since 20 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97724723
- Registration number
- 7308835
- Mark type
- Stylized text
- Filed
- 20 Dec 2022
- Published for opposition
- 05 Dec 2023
- Registered
- 20 Feb 2024
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing excluding topical anesthetics
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 20 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Dec 2023 — PUBLISHED FOR OPPOSITION
- 15 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Sept 2023 — NON-FINAL ACTION E-MAILED
- 25 Sept 2023 — NON-FINAL ACTION WRITTEN
- 19 Sept 2023 — ASSIGNED TO EXAMINER
- 12 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED